Wen et al. [77] followed a similar rationale to load another anticancer drug (Sor) and EGFR onto multiwall CNTs (MWNTs): the results showed that this nanocomposite could decrease tumor growth in liver cancer cells, mostly by apoptosis. This evidence concerns the gene EGFR and neoplasm.